As it cuts crucial programs, the premier's budget still contains some generous funding for billionaires, corporations and ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Gold & silver outlook: record volatility, but bullish. Regulatory interventions, such as CME margin hikes, may temporarily ...